{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:34:15Z","timestamp":1773282855293,"version":"3.50.1"},"reference-count":114,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.beem.2006.02.002","type":"journal-article","created":{"date-parts":[[2006,6,13]],"date-time":"2006-06-13T11:22:33Z","timestamp":1150197753000},"page":"311-330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Treatment of PCOS in adolescence"],"prefix":"10.1016","volume":"20","author":[{"given":"Julia","family":"Warren-Ulanch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silva","family":"Arslanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2006.02.002_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1083-3188(02)00205-X","article-title":"Fertility concerns and sexual behavior in adolescent girls with polycystic ovary syndrome: implications for quality of life","volume":"16","author":"Trent","year":"2003","journal-title":"Journal of Pediatric and Adolescent Gynecology"},{"key":"10.1016\/j.beem.2006.02.002_bib2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1367\/A04-130R.1","article-title":"Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life","volume":"5","author":"Trent","year":"2005","journal-title":"Ambulatory Pediatrics"},{"key":"10.1016\/j.beem.2006.02.002_bib3","series-title":"Polycystic Ovary Syndrome","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"Zawadzki","year":"1992"},{"issue":"supplement 5","key":"10.1016\/j.beem.2006.02.002_bib4","first-page":"1285","article-title":"Diagnosis of the polycystic ovary syndrome in adolescence: comparison of adolescent and adult hyperandrogenism","volume":"13","author":"Rosenfield","year":"2000","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1749-6632.2000.tb06236.x","article-title":"Combined oral contraceptive treatment of adolescent girls with polycystic ovary syndrome. Lipid profile","volume":"900","author":"Creatsas","year":"2000","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.beem.2006.02.002_bib6","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1365-2265.1985.tb00165.x","article-title":"Premenarcheal endocrine changes in relation to age at menarche","volume":"22","author":"Apter","year":"1985","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.beem.2006.02.002_bib7","doi-asserted-by":"crossref","unstructured":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility, 2004; 81, pp. 19\u201325.","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"10.1016\/j.beem.2006.02.002_bib8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0015-0282(16)56160-3","article-title":"Standards for ovarian volume in childhood and puberty","volume":"60","author":"Bridges","year":"1993","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.beem.2006.02.002_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00019616-200207000-00011","article-title":"Polycystic ovary syndrome in adolescence","volume":"12","author":"Baumann","year":"2002","journal-title":"Endocrinologist"},{"key":"10.1016\/j.beem.2006.02.002_bib10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/humrep\/deh079","article-title":"Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years","volume":"19","author":"van Hooff","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1016\/j.beem.2006.02.002_bib11","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/humrep\/deh207","article-title":"Polycystic ovary syndrome in adolescence\u2014a therapeutic conundrum","volume":"19","author":"Homburg","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1016\/j.beem.2006.02.002_bib12","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1210\/jcem.86.8.7756","article-title":"Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism","volume":"86","author":"Ibanez","year":"2001","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0889-8545(00)80008-X","article-title":"Disorders of excessive hair growth in the adolescent","volume":"27","author":"Plouffe","year":"2000","journal-title":"Obstetrics and Gynecology Clinics of North America"},{"key":"10.1016\/j.beem.2006.02.002_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1083-3188(97)70072-X","article-title":"Clinical, endocrinologic, and ultrasonographic features of polycystic ovary syndrome in Singaporean adolescents","volume":"10","author":"Dramusic","year":"1997","journal-title":"Journal of Pediatric and Adolescent Gynecology"},{"key":"10.1016\/j.beem.2006.02.002_bib15","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1210\/jc.2003-031281","article-title":"Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity","volume":"89","author":"Ibanez","year":"2004","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib16","doi-asserted-by":"crossref","first-page":"27S","DOI":"10.1016\/S0002-9343(99)80056-4","article-title":"Obesity, lipids, cardiovascular risk, and androgen excess","volume":"98","author":"Wild","year":"1995","journal-title":"The American Journal of Medicine"},{"key":"10.1016\/j.beem.2006.02.002_bib17","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1210\/jc.2003-030617","article-title":"Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents","volume":"88","author":"Silfen","year":"2003","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpeds.2003.08.015","article-title":"Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome","volume":"144","author":"Ibanez","year":"2004","journal-title":"Journal of Pediatrics"},{"key":"10.1016\/j.beem.2006.02.002_bib19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/153537020422900504","article-title":"Screening for and treatment of polycystic ovary syndrome in teenagers","volume":"229","author":"Salmi","year":"2004","journal-title":"Experimental Biology and Medicine (Maywood)"},{"key":"10.1016\/j.beem.2006.02.002_bib20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jpeds.2003.10.032","article-title":"Polycystic ovary syndrome: what is it and how should we treat it?","volume":"144","author":"Cedars","year":"2004","journal-title":"Journal of Pediatrics"},{"key":"10.1016\/j.beem.2006.02.002_bib21","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/BF03350784","article-title":"Polycystic ovary syndrome and insulin resistance: thrifty genes struggling with over-feeding and sedentary life style?","volume":"21","author":"Holte","year":"1998","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1016\/j.beem.2006.02.002_bib22","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1210\/jcem.83.10.5205","article-title":"Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth","volume":"83","author":"Ibanez","year":"1998","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib23","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1210\/jcem.87.7.8657","article-title":"Reduced ovulation rate in adolescent girls born small for gestational age","volume":"87","author":"Ibanez","year":"2002","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/BF00399095","article-title":"Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth","volume":"36","author":"Barker","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.beem.2006.02.002_bib25","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/bmj.303.6809.1019","article-title":"Fetal and infant growth and impaired glucose tolerance at age 64","volume":"303","author":"Hales","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.beem.2006.02.002_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ije\/30.1.15","article-title":"The nutritional basis of the fetal origins of adult disease","volume":"30","author":"Harding","year":"2001","journal-title":"International Journal of Epidemiology"},{"key":"10.1016\/j.beem.2006.02.002_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF00399954","article-title":"Fetal growth and impaired glucose tolerance in men and women","volume":"36","author":"Phipps","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.beem.2006.02.002_bib28","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/sj.ijo.0801821","article-title":"Abdominal fat and birth size in healthy prepubertal children","volume":"25","author":"Garnett","year":"2001","journal-title":"International Journal of Obesity and Related Metabolic Disorders"},{"key":"10.1016\/j.beem.2006.02.002_bib29","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/adc.2004.053959","article-title":"Precocious pubarche is associated with SGA, prematurity, weight gain, and obesity","volume":"90","author":"Neville","year":"2005","journal-title":"Archives of Disease in Childhood"},{"key":"10.1016\/j.beem.2006.02.002_bib30","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/sj.ijo.0802301","article-title":"Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms","volume":"27","author":"Laitinen","year":"2003","journal-title":"International Journal of Obesity and Related Metabolic Disorders"},{"key":"10.1016\/j.beem.2006.02.002_bib31","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1210\/jcem.84.11.6106","article-title":"Intrauterine growth retardation predisposes to insulin resistance but not to hyperandrogenism in young women","volume":"84","author":"Jaquet","year":"1999","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib32","first-page":"1599","article-title":"Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism","volume":"76","author":"Ibanez","year":"1993","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib33","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1210\/jc.2004-0463","article-title":"Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment","volume":"89","author":"Ibanez","year":"2004","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib34","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1542\/peds.108.2.347","article-title":"Earlier onset of puberty in girls: relation to increased body mass index and race","volume":"108","author":"Kaplowitz","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.beem.2006.02.002_bib35","series-title":"Adolescence in Females","first-page":"363","article-title":"Relationship between onset of obesity and onset of oligomenorrhea or amenorrhea in females with obesity and polycystic ovaries","author":"Pasquali","year":"1985"},{"key":"10.1016\/j.beem.2006.02.002_bib36","first-page":"3936","article-title":"Role of nutritional status in the regulation of adrenarche","volume":"84","author":"Remer","year":"1999","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1210\/jc.2002-020982","article-title":"Hormonal profile of women with self-reported symptoms of oligomenorrhea and\/or hirsutism: Northern Finland birth cohort 1966 study","volume":"88","author":"Taponen","year":"2003","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/07315724.1991.10718155","article-title":"Excess weight and precocious pubarche in children: alterations of the adrenocortical hormones","volume":"10","author":"Jabbar","year":"1991","journal-title":"Journal of the American College of Nutrition"},{"key":"10.1016\/j.beem.2006.02.002_bib39","first-page":"2966","article-title":"Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism","volume":"80","author":"Apter","year":"1995","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1067\/mpd.2001.109603","article-title":"Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome","volume":"138","author":"Lewy","year":"2001","journal-title":"Journal of Pediatrics"},{"key":"10.1016\/j.beem.2006.02.002_bib41","first-page":"2694","article-title":"A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome","volume":"83","author":"Legro","year":"1998","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib42","series-title":"Type 2 Diabetes in Childhood and Adolescence","first-page":"93","article-title":"Insulin resistance and insulin secretion in childhood and adolescence: their role in type 2 diabetes in youth","author":"Arslanian","year":"2003"},{"key":"10.1016\/j.beem.2006.02.002_bib43","first-page":"73","article-title":"Polycystic ovary syndrome in adolescents","volume":"13","author":"Kent","year":"2002","journal-title":"Adolescent Medicine"},{"key":"10.1016\/j.beem.2006.02.002_bib44","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1210\/jcem.87.3.8305","article-title":"Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome","volume":"87","author":"Palmert","year":"2002","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib45","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0015-0282(02)02993-X","article-title":"Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives","volume":"77","author":"Mastorakos","year":"2002","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.beem.2006.02.002_bib46","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2337\/diab.45.2.242","article-title":"Report of the American Diabetes Association's Task Force on standardization of the insulin assay","volume":"45","author":"Robbins","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2006.02.002_bib47","first-page":"942","article-title":"Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome","volume":"81","author":"Dunaif","year":"1996","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib48","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1172\/JCI118064","article-title":"Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus","volume":"96","author":"Ehrmann","year":"1995","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.beem.2006.02.002_bib49","first-page":"66","article-title":"Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease","volume":"86","author":"Arslanian","year":"2001","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"supplement 5","key":"10.1016\/j.beem.2006.02.002_bib50","first-page":"1367","article-title":"Detection of insulin resistance and its treatment in adolescents with polycystic ovary syndrome","volume":"15","author":"Legro","year":"2002","journal-title":"Journal of Pediatric Endocrinology & Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib51","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib52","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1399-543X.2005.00097.x","article-title":"Progression from normal glucose tolerance to type 2 diabetes in a young girl: longitudinal changes in insulin sensitivity and secretion assessed by the clamp technique and surrogate estimates","volume":"6","author":"Saad","year":"2005","journal-title":"Pediatric Diabetes"},{"key":"10.1016\/j.beem.2006.02.002_bib53","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1210\/jc.2003-030117","article-title":"Flutamide\u2013metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception","volume":"88","author":"Ibanez","year":"2003","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib54","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1210\/jc.2002-022002","article-title":"Low-dose flutamide\u2013metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism","volume":"88","author":"Ibanez","year":"2003","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib55","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2337\/diacare.27.2.547","article-title":"Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function","volume":"27","author":"Bacha","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2006.02.002_bib56","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1210\/jc.2002-021688","article-title":"Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome","volume":"88","author":"Morin-Papunen","year":"2003","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib57","first-page":"165","article-title":"Elevated serum TNF-alpha levels in normal-weight women with polycystic ovaries or the polycystic ovary syndrome","volume":"48","author":"Sayin","year":"2003","journal-title":"The Journal of Reproductive Medicine"},{"key":"10.1016\/j.beem.2006.02.002_bib58","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1507\/endocrj.51.467","article-title":"The plasminogen activator system in young and lean women with polycystic ovary syndrome","volume":"51","author":"Tarkun","year":"2004","journal-title":"Endocrine Journal"},{"key":"10.1016\/j.beem.2006.02.002_bib59","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0895-4356(98)00035-3","article-title":"Mortality of women with polycystic ovary syndrome at long-term follow-up","volume":"51","author":"Pierpoint","year":"1998","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1016\/j.beem.2006.02.002_bib60","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2265.2000.01000.x","article-title":"Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study","volume":"52","author":"Wild","year":"2000","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.beem.2006.02.002_bib61","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1210\/jcem.86.10.7904","article-title":"Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy","volume":"86","author":"Diamanti-Kandarakis","year":"2001","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib62","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.atherosclerosis.2004.04.007","article-title":"Intima-media thickness of elastic and muscular arteries of young women with polycystic ovaries","volume":"175","author":"Lakhani","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.beem.2006.02.002_bib63","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1210\/jc.2004-1487","article-title":"Vascular dysfunction and metabolic parameters in polycystic ovary syndrome","volume":"90","author":"Meyer","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib64","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1210\/jc.2003-031867","article-title":"Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome","volume":"89","author":"Orio","year":"2004","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib65","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1210\/jc.2004-2363","article-title":"Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome","volume":"90","author":"Vryonidou","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib66","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0889-8529(05)70070-0","article-title":"Ovarian and adrenal function in polycystic ovary syndrome","volume":"28","author":"Rosenfield","year":"1999","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"key":"10.1016\/j.beem.2006.02.002_bib67","first-page":"881","article-title":"Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity","volume":"81","author":"Moghetti","year":"1996","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib68","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jcem.87.4.8398","article-title":"Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia\/insulin resistance","volume":"87","author":"Arslanian","year":"2002","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"supplement 5","key":"10.1016\/j.beem.2006.02.002_bib69","first-page":"1303","article-title":"Family history as a risk factor for the polycystic ovary syndrome","volume":"13","author":"Azziz","year":"2000","journal-title":"Journal of Pediatric Endocrinology & Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib70","first-page":"2027","article-title":"Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives","volume":"86","author":"Colilla","year":"2001","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib71","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1210\/jc.2002-021499","article-title":"Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome","volume":"88","author":"Yildiz","year":"2003","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib72","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0015-0282(00)01526-0","article-title":"The time has come to simplify the evaluation of the hirsute patient","volume":"74","author":"Azziz","year":"2000","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.beem.2006.02.002_bib73","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0889-8545(03)00028-7","article-title":"Treatment of the adolescent patient with polycystic ovary syndrome","volume":"30","author":"Pfeifer","year":"2003","journal-title":"Obstetrics and Gynecology Clinics of North America"},{"key":"10.1016\/j.beem.2006.02.002_bib74","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1210\/jc.2003-030934","article-title":"The hormonal phenotype of Nonclassic 3 beta-hydroxysteroid dehydrogenase (HSD3B) deficiency in hyperandrogenic females is associated with insulin-resistant polycystic ovary syndrome and is not a variant of inherited HSD3B2 deficiency","volume":"89","author":"Carbunaru","year":"2004","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib75","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1196\/annals.1315.009","article-title":"An update of congenital adrenal hyperplasia","volume":"1038","author":"New","year":"2004","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"supplement 1","key":"10.1016\/j.beem.2006.02.002_bib76","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1017\/S0007114500001070","article-title":"The finnish diabetes prevention study","volume":"83","author":"Uusitupa","year":"2000","journal-title":"The British Journal of Nutrition"},{"key":"10.1016\/j.beem.2006.02.002_bib77","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2006.02.002_bib78","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","article-title":"Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome","volume":"36","author":"Kiddy","year":"1992","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.beem.2006.02.002_bib79","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0015-0282(16)56632-1","article-title":"Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women","volume":"61","author":"Guzick","year":"1994","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.beem.2006.02.002_bib80","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1210\/jcem-68-1-173","article-title":"Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss","volume":"68","author":"Pasquali","year":"1989","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib81","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1210\/jc.2001-012056","article-title":"Exercise decreases plasma total homocysteine in overweight young women with polycystic ovary syndrome","volume":"87","author":"Randeva","year":"2002","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib82","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1056\/NEJM199708073370606","article-title":"Obesity","volume":"337","author":"Rosenbaum","year":"1997","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2006.02.002_bib83","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1001\/jama.1990.03450190051027","article-title":"Ten-year follow-up of behavioral, family-based treatment for obese children","volume":"264","author":"Epstein","year":"1990","journal-title":"JMMA"},{"key":"10.1016\/j.beem.2006.02.002_bib84","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/oby.2005.101","article-title":"The relationship of health outcomes to improvement in BMI in children and adolescents","volume":"13","author":"Kirk","year":"2005","journal-title":"Obesity Research"},{"key":"10.1016\/j.beem.2006.02.002_bib85","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.fertnstert.2004.02.104","article-title":"A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and\/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study","volume":"82","author":"Hoeger","year":"2004","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.beem.2006.02.002_bib86","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","article-title":"Drospirenone: pharmacology and pharmacokinetics of a unique progestogen","volume":"62","author":"Krattenmacher","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2006.02.002_bib87","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/humrep\/deh329","article-title":"Flutamide\u2013metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity","volume":"19","author":"Ibanez","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1016\/j.beem.2006.02.002_bib88","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00060793-200202000-00006","article-title":"Polycystic ovary syndrome in adolescents: is there an epidemic?","volume":"9","author":"Arslanian","year":"2002","journal-title":"Current Opinion in Endocrinology Diabetes"},{"key":"10.1016\/j.beem.2006.02.002_bib89","first-page":"3251","article-title":"Treatment of hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism in nonobese, adolescent girls: effect of flutamide","volume":"85","author":"Ibanez","year":"2000","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib90","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1054-139X(01)00202-6","article-title":"Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS)","volume":"29","author":"Glueck","year":"2001","journal-title":"The Journal of Adolescent Health"},{"key":"10.1016\/j.beem.2006.02.002_bib91","doi-asserted-by":"crossref","first-page":"5702","DOI":"10.1210\/jc.2002-020926","article-title":"Anovulation in eumenorrheic, nonobese adolescent girls born small for gestational age: insulin sensitization induces ovulation, increases lean body mass, and reduces abdominal fat excess, dyslipidemia, and subclinical hyperandrogenism","volume":"87","author":"Ibanez","year":"2002","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib92","doi-asserted-by":"crossref","first-page":"16767","DOI":"10.1074\/jbc.M100040200","article-title":"Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3beta -hydroxysteroid dehydrogenase","volume":"276","author":"Arlt","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.beem.2006.02.002_bib93","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/humrep\/deh145","article-title":"Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome","volume":"19","author":"Guido","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1016\/j.beem.2006.02.002_bib94","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1210\/jc.2004-1376","article-title":"Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance","volume":"90","author":"Sepilian","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib95","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2004-1965","article-title":"Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome","volume":"90","author":"Ortega-Gonzalez","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib96","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1515\/JPEM.2005.18.5.499","article-title":"Approach to adolescent polycystic ovary syndrome (PCOS) in the pediatric endocrine community in the USA","volume":"18","author":"Guttmann-Bauman","year":"2005","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib97","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0303-7207(86)90132-2","article-title":"Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues","volume":"44","author":"Simard","year":"1986","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.beem.2006.02.002_bib98","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0015-0282(00)01764-7","article-title":"Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism","volume":"75","author":"Sahin","year":"2001","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.beem.2006.02.002_bib99","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1749-6632.1993.tb43875.x","article-title":"Results of an open one-year study with Diane-35 in women with polycystic ovarian syndrome","volume":"687","author":"Golland","year":"1993","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.beem.2006.02.002_bib100","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-0029-1211357","article-title":"Experience in the long-term treatment of patients with hirsutism and\/or acne with cyproterone acetate-containing preparations: efficacy, metabolic and endocrine effects","volume":"103","author":"van Wayjen","year":"1995","journal-title":"Experimental and Clinical Endocrinology and Diabetes"},{"key":"10.1016\/j.beem.2006.02.002_bib101","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1210\/jc.2003-030424","article-title":"Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome","volume":"88","author":"Harborne","year":"2003","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib102","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/pds.896","article-title":"Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette): observational studies using the UK General Practice Research Database","volume":"13","author":"Seaman","year":"2004","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1016\/j.beem.2006.02.002_bib103","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1210\/jc.2003-031780","article-title":"Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study","volume":"89","author":"Ganie","year":"2004","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib104","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF03345529","article-title":"Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile","volume":"28","author":"Zulian","year":"2005","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1016\/j.beem.2006.02.002_bib105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/jc.2004-1405","article-title":"Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy","volume":"90","author":"Ibanez","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib106","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1210\/jc.2004-2283","article-title":"Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses","volume":"90","author":"Harborne","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib107","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0015-0282(16)58387-3","article-title":"Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist","volume":"66","author":"Ruchhoft","year":"1996","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.beem.2006.02.002_bib108","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.2165\/00003495-200464210-00006","article-title":"Long-cycle treatment with oral contraceptives","volume":"64","author":"Wiegratz","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.beem.2006.02.002_bib109","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1210\/jc.2002-021528","article-title":"A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills","volume":"88","author":"Diamanti-Kandarakis","year":"2003","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib110","first-page":"125","article-title":"A cyproterone acetate-ethinyl estradiol combination in the treatment of acne. Data of a survey of gynecologists","volume":"40","author":"Vignini","year":"1988","journal-title":"Minerva Ginecologica"},{"key":"10.1016\/j.beem.2006.02.002_bib111","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s007740170029","article-title":"Relationship between bone mineral density and insulin resistance in polycystic ovary syndrome","volume":"19","author":"Yuksel","year":"2001","journal-title":"Journal of Bone and Mineral Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib112","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1210\/jcem.85.10.6902","article-title":"Clinical Review 116: Bone mineral density, androgens, and the polycystic ovary: the complex and controversial issue of androgenic influence in female bone","volume":"85","author":"Zborowski","year":"2000","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.02.002_bib113","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jadohealth.2004.07.005","article-title":"Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls","volume":"35","author":"Cromer","year":"2004","journal-title":"The Journal of Adolescent Health"},{"key":"10.1016\/j.beem.2006.02.002_bib114","unstructured":"Warren-Ulanch J, Greenspan S, Arslanian S. Bone mass and turnover in adolescents with polycystic ovary syndrome: effects of treatment with metformin. 87th Annual Meeting of the Endocrine Society 2005, [Program and Abstracts: #P2-395, p. 453]."}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X06000169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X06000169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:36:13Z","timestamp":1761496573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X06000169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":114,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S1521690X06000169"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2006.02.002","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of PCOS in adolescence","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2006.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}